Cantitate/Preț
Produs
Total produse
Vezi coșul
Chronic Myeloproliferative Disorders de Tariq Mughal

Chronic Myeloproliferative Disorders

Editat de Tariq Mughal, John M. Goldman
en Limba Engleză Hardback – 27 aug 2008
With the new classification of chronic myeloproliferative disorders, and the rise of interest in molecularly targeted therapies, this timely text brings together international experts on the topic to discuss the current technologies and their implications for the treatment of patients.
This title comprehensively covers chronic myeloid leukemia and Ph-negative chronic myeloproliferative disorders and is an essential resource for all practitioners in Hematologic Oncology.
Citește tot Restrânge

Preț: 80820 lei

Preț vechi: 103216 lei
-22%

Puncte Express: 1212
Preț estimativ în valută:
14293€ • 16498$ • 12352£

Carte indisponibilă temporar


Wish list
Gift list
Am citit!
Adaugă în listă
Doresc să fiu notificat când acest titlu va fi disponibil:
Trimite

Specificații

ISBN-13: 9780415415989
ISBN-10: 0415415985
Pagini: 272
Ilustrații: 34 tables, 14 color halftones and 18 color line drawings
Dimensiuni: 189 x 246 x 18 mm
Greutate: 0.61 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press

Public țintă

Professional and Professional Reference

Cuprins

I. Bcr/Abl Positive Chronic Myeloproliferative Disorders. 1. Epidemiology and history. 2. Cytogenetics and molecular biology. 3. Risk stratification. 4. Clinical features. 5. Non-transplant treatment options. 6. Allogeneic stem cell transplantation. 7. Autologous stem cell transplantation. 8. Vaccines. 9. A therapeutic algorithm and concluding remarks. II. Bcr/Abl Negative Chronic Myeloproliferative Disorders. 10. Epidemiology and history. 11. Cytogenetics and molecular biology. 12. Risk stratification. 13. Clinical features. 14. Non-transplant treatment options. 15. Transplantation options. 16. A therapeutic algorithm and concluding remarks.

Notă biografică

TARIQ I MUGHAL is Professor of Medicine and Haematology/Oncology at the University of Texas Southwestern Medical School, Dallas, USA and Consultant Haematologist at Guy’s & St Thomas’ Hospitals, London UK
JOHN M. GOLDMAN is Professor of Haematology at Imperial College London, Hammersmith Hospital, London, UK.

Descriere

With the new classification of chronic myeloproliferative disorders, and the rise of interest in molecularly targeted therapies, this timely text brings together international experts on the topic to discuss the current technologies and their implications for the treatment of patients.
This title comprehensively covers chronic myeloid leukemia and Ph-negative chronic myeloproliferative disorders and is an essential resource for all practitioners in Hematologic Oncology.